AAAAAA
Results:
1-13
|
Results: 13
Authors:
Winston, DJ
Lazarus, HM
Beveridge, RA
Hathorn, JW
Gucalp, R
Ramphal, R
Chow, AW
Ho, WG
Horn, R
Feld, R
Louie, TJ
Territo, MC
Blumer, JL
Tack, KJ
Citation: Dj. Winston et al., Randomized, double-blind, multicenter trial comparing clinafloxacin with imipenem as empirical monotherapy for febrile granulocytopenic patients, CLIN INF D, 32(3), 2001, pp. 381-390
Authors:
Feld, R
Woodside, DB
Kaplan, AS
Olmsted, MP
Carter, JC
Citation: R. Feld et al., Pretreatment motivational enhancement therapy for eating disorders: A pilot study, INT J EAT D, 29(4), 2001, pp. 393-400
Authors:
Joseph, MG
Banerjee, D
Kocha, W
Feld, R
Stitt, LW
Cherian, MG
Citation: Mg. Joseph et al., Metallothionein expression in patients with small cell carcinoma of the lung - Correlation with other molecular markers and clinical outcome, CANCER, 92(4), 2001, pp. 836-842
Authors:
Knox, JJ
Puodziunas, ALV
Feld, R
Citation: Jj. Knox et al., Chemotherapy-induced oral mucositis - Prevention and management, DRUG AGING, 17(4), 2000, pp. 257-267
Authors:
Feld, R
Citation: R. Feld, Multinational cooperation in trials and guidelines dealing with febrile neutropenia, INT J ANT A, 16(2), 2000, pp. 185-187
Authors:
Feld, R
DePauw, B
Berman, S
Keating, A
Ho, W
Citation: R. Feld et al., Meropenem versus ceftazidime in the treatment of cancer patients with febrile neutropenia: A randomized, double-blind trial, J CL ONCOL, 18(21), 2000, pp. 3690-3698
Authors:
Klastersky, J
Paesmans, M
Rubenstein, EB
Boyer, M
Elting, L
Feld, R
Gallagher, J
Herrstedt, J
Rapoport, B
Rolston, K
Talcott, J
Citation: J. Klastersky et al., The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients, J CL ONCOL, 18(16), 2000, pp. 3038-3051
Authors:
Thomas, P
Khokha, R
Shepherd, FA
Feld, R
Tsao, MS
Citation: P. Thomas et al., Differential expression of matrix metalloproteinases and their inhibitors in non-small cell lung cancer, J PATHOLOGY, 190(2), 2000, pp. 150-156
Authors:
Feld, R
Citation: R. Feld, Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: Pros and cons, CLIN INF D, 29(3), 1999, pp. 503-507
Authors:
Quon, H
Shepherd, FA
Payne, DG
Coy, P
Murray, N
Feld, R
Pater, J
Sadura, A
Zee, B
Citation: H. Quon et al., The influence of age on the delivery, tolerance, and efficacy of thoracic irradiation in the combined modality treatment of limited stage small cell lung cancer, INT J RAD O, 43(1), 1999, pp. 39-45
Authors:
Feld, R
Citation: R. Feld, Microbial resistance and the Infectious Diseases Society of America (IDSA)guidelines, INT J HEMAT, 68, 1998, pp. S27-S30
Authors:
Dompeling, EC
Donnelly, JP
Raemaekers, JMM
Deresinski, SC
Feld, R
De Pauw, BE
Citation: Ec. Dompeling et al., Evolution of the clinical manifestations of infection during the course offebrile neutropenia in patients with malignancy, INFECTION, 26(6), 1998, pp. 349-354
Authors:
Shepherd, FA
Payne, DG
Feld, R
Murray, N
Siu, L
Quon, H
Pater, J
Zee, B
Citation: Fa. Shepherd et al., Combined modality therapy for elderly patients with limited small cell lung cancer, TREATMENT OPTIMIZATION FOR LUNG CANCER, 1998, pp. 249-259
Risultati:
1-13
|